Notably, COL11A1 binds to α1β1 integrin and DDR2 to activate the Src-phosphatidylinositol 3-kinase (PI3K)/AKT-NFκB pathway to induce the expression of three cisplatin-induced apoptosis inhibitors in ovarian cancer (25). This evidence concerns the gene AKT1 and ovarian carcinoma.